More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling

Peter Bader, Emilia Salzmann‐Manrique, Adriana Balduzzi, +21

Blood Advances

Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone

Nathan Gossai, Megan V. Hilgers, Lynda E. Polgreen, +1

Pediatric Blood & Cancer

Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia

Amy K. Keating, Nathan Gossai, Christine L. Phillips, +6

Blood Advances

Mixed-phenotype Acute LeukemiaPathologyHematological MalignancyOncologyHematology +14

Report of a patient with a constitutional missense mutation in <i>SMARCB1</i>, Coffin–Siris phenotype, and schwannomatosis

Nathan Gossai, Jaclyn A. Biegel, Ludwine Messiaen, +2

American Journal of Medical Genetics Part A

Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium

Yana Pikman, Sarah K. Tasian, Maria Luisa Sulis, +50

Cancer Discovery

Survival Differences between Adolescents/Young Adults and Children with B Precursor Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplantation

Michael J. Burke, Nathan Gossai, John E. Wagner, +7

Biology of Blood and Marrow Transplantation

Decitabine and vorinostat with <scp>FLAG</scp> chemotherapy in pediatric relapsed/refractory <scp>AML</scp>: Report from the therapeutic advances in childhood leukemia and lymphoma (<scp>TACL</scp>) consortium

Lauren Pommert, Eric S. Schafer, Jemily Malvar, +24

American Journal of Hematology

Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children’s Oncology Group report

Nathan Gossai, Meenakshi Devidas, Zhiguo Chen, +15

Blood

Similar outcomes between adolescent/young adults and children with AML following allogeneic hematopoietic cell transplantation

Michael J. Burke, Nathan Gossai, Qing Cao, +3

Bone Marrow Transplantation

Similar OutcomesTransplantationMarrow TransplantationPediatric HematologyStem Cell Transplantation +7

Drug conjugated nanoparticles activated by cancer cell specific mRNA

Nathan Gossai, Jordan A. Naumann, Nan‐Sheng Li, +4

Oncotarget

NanoparticlesNanomedicineNanotherapeuticsEngineeringPolymer-drug Conjugate +10